Home › Funds › Portolan Capital Management, LLC › GENI
Portolan Capital Management, LLC position in GENI
GENIUS SPORTS LIMITED · Consumer Discretionary
Portolan Capital Management, LLC reported holding 8,913,656 shares of GENI (GENIUS SPORTS LIMITED) in its Q3 2026 13F filing — a position valued at US$51.1M, representing 2.13% of its reported portfolio and ranking #7 among its reported holdings. Portolan Capital Management, LLC has disclosed GENI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Portolan Capital Management, LLC's GENI position evolved
Portolan Capital Management, LLC first disclosed a stake in GENI in Q3 2023 at 3,112,178 shares (US$16.6M). The position peaked in Q3 2026 at 8,913,656 shares, worth US$51.1M. Across 13 filings, Portolan Capital Management, LLC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,913,656 shares valued at US$51.1M — an increase of 1,887,847 shares quarter over quarter.. Notable position changes include a 32% increase in Q2 2024 (shares rose 44% over the following quarter), a 39% increase in Q1 2025 (shares rose 4% over the following quarter), a 152% increase in Q2 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.11M | $16.59M | New |
| Q4 2023 | 2.38M | $14.73M | Reduce |
| Q1 2024 | 2.20M | $12.59M | Reduce |
| Q2 2024 | 2.90M | $15.80M | Add |
| Q3 2024 | 3.17M | $24.86M | Add |
| Q4 2024 | 3.07M | $26.55M | Reduce |
| Q1 2025 | 4.28M | $42.86M | Add |
| Q2 2025 | 4.09M | $42.50M | Reduce |
| Q3 2025 | 3.61M | $44.73M | Reduce |
| Q4 2025 | 2.94M | $32.38M | Reduce |
| Q1 2026 | 2.79M | $12.36M | Reduce |
| Q2 2026 | 7.03M | $42.58M | Add |
| Q3 2026 | 8.91M | $51.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GENI and 13F data
GENI (GENIUS SPORTS LIMITED) is a Consumer Discretionary company. 22 other funds we track also report a position in GENI — the largest reported positions include Senvest Management, LLC (US$104.1M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$95.2M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$61.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GENI
- Senvest Management, LLC 18.18M sh · $104.15M · Q3 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 16.62M sh · $95.24M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 10.72M sh · $61.40M · Q3 2026
- SHAPIRO CAPITAL MANAGEMENT LLC 9.79M sh · $56.10M · Q3 2026
- Granahan Investment Management, LLC 8.14M sh · $46.63M · Q3 2026
- CYPRESS POINT INVESTMENT MANAGEMENT LP 6.21M sh · $35.57M · Q3 2026
- NEEDHAM INVESTMENT MANAGEMENT LLC 5.20M sh · $29.80M · Q3 2026
- Samjo Management, LLC 5.14M sh · $29.48M · Q3 2026
- Divisadero Street Capital Management, LP 5.13M sh · $29.38M · Q3 2026
- DISCOVERY CAPITAL MANAGEMENT, LLC / CT 4.79M sh · $27.42M · Q3 2026
- Longaeva Partners L.P. 4.47M sh · $25.59M · Q3 2026
- IFC Advisors LLC 4.00M sh · $22.94M · Q3 2026
More on Portolan Capital Management, LLC
FAQ
How long has Portolan Capital Management, LLC held GENI?
Portolan Capital Management, LLC has disclosed GENI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Portolan Capital Management, LLC's current position in GENI?
As of Q3 2026, Portolan Capital Management, LLC holds 8.91M shares of GENI (GENIUS SPORTS LIMITED), valued at $51.08M, representing 2.13% of its reported portfolio and ranking #7.
Has Portolan Capital Management, LLC been buying or selling GENI?
In the latest 13F filing (Q3 2026), Portolan Capital Management, LLC increased its position in GENI. The position peaked in Q3 2026 at 8.91M shares.
Which other funds hold GENI?
Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.